Pell Bio-Med Technology Co., Ltd. (TPE:6949)
159.50
-1.00 (-0.62%)
Jul 11, 2025, 1:35 PM CST
Pell Bio-Med Technology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 558.47 | 427.37 | 167.68 | 172.4 | 115.78 |
Short-Term Investments | 449.75 | 679.75 | 938.15 | 536 | - |
Trading Asset Securities | 17.7 | 29.06 | - | - | - |
Cash & Short-Term Investments | 1,026 | 1,136 | 1,106 | 708.4 | 115.78 |
Cash Growth | -24.20% | 2.74% | 56.10% | 511.84% | - |
Accounts Receivable | 3.17 | 3.75 | 7.61 | 6.05 | 4.5 |
Other Receivables | 2.57 | 0.56 | 0.33 | 0.36 | 6.12 |
Receivables | 5.73 | 4.31 | 7.94 | 6.41 | 10.62 |
Inventory | 6.24 | 6.18 | 3.76 | 4.58 | 4.24 |
Prepaid Expenses | 8.87 | 9.22 | 8.86 | 5.84 | 1.1 |
Other Current Assets | - | 1.84 | 0.65 | 0.16 | 0.08 |
Total Current Assets | 1,047 | 1,158 | 1,127 | 725.39 | 131.82 |
Property, Plant & Equipment | 485.13 | 386.45 | 260.92 | 298.97 | 249.74 |
Long-Term Investments | 0.37 | 0.37 | 0.37 | 0.26 | 0.26 |
Other Intangible Assets | 1.86 | 1.89 | 2.4 | 2.71 | 1.47 |
Other Long-Term Assets | 141.88 | 198.39 | 27.44 | 17.07 | 10.61 |
Total Assets | 1,676 | 1,745 | 1,418 | 1,044 | 393.89 |
Accounts Payable | 3.38 | 4.49 | 6.99 | 5.72 | 8.61 |
Accrued Expenses | 81.82 | 64.12 | 39.74 | 14.58 | 19.19 |
Short-Term Debt | 200 | 200 | - | 5 | - |
Current Portion of Leases | 27.66 | 27.55 | 25.09 | 25.07 | 10.76 |
Current Unearned Revenue | - | - | - | - | 0.75 |
Other Current Liabilities | 11.69 | 25.19 | 17.47 | 6.86 | 4.87 |
Total Current Liabilities | 324.56 | 321.35 | 89.3 | 57.24 | 44.18 |
Long-Term Leases | 130.31 | 137.27 | 147.47 | 172.56 | 124.84 |
Total Liabilities | 454.87 | 458.62 | 236.77 | 229.79 | 169.02 |
Common Stock | 581.19 | 578.43 | 539.43 | 443.65 | 333.76 |
Additional Paid-In Capital | 1,813 | 1,804 | 1,449 | 774.25 | 77.38 |
Retained Earnings | -1,283 | -1,207 | -817.85 | -419.09 | -188.96 |
Treasury Stock | -0.8 | -0.8 | -0.8 | - | - |
Comprehensive Income & Other | 5.47 | 5.52 | - | 2.13 | 2.69 |
Total Common Equity | 1,116 | 1,180 | 1,170 | 800.94 | 224.86 |
Minority Interest | 104.8 | 106.29 | 11.18 | 13.67 | 0.01 |
Shareholders' Equity | 1,221 | 1,286 | 1,181 | 814.6 | 224.87 |
Total Liabilities & Equity | 1,676 | 1,745 | 1,418 | 1,044 | 393.89 |
Total Debt | 357.97 | 364.82 | 172.56 | 202.63 | 135.6 |
Net Cash (Debt) | 667.95 | 771.36 | 933.27 | 505.77 | -19.82 |
Net Cash Growth | -43.72% | -17.35% | 84.52% | - | - |
Net Cash Per Share | 11.53 | 13.52 | 20.17 | 12.89 | -0.60 |
Filing Date Shares Outstanding | 58.08 | 57.8 | 53.9 | 44.36 | 33.28 |
Total Common Shares Outstanding | 58.08 | 57.8 | 53.9 | 44.36 | 33.28 |
Working Capital | 722.21 | 836.38 | 1,038 | 668.15 | 87.64 |
Book Value Per Share | 19.22 | 20.41 | 21.71 | 18.05 | 6.76 |
Tangible Book Value | 1,114 | 1,178 | 1,168 | 798.22 | 223.39 |
Tangible Book Value Per Share | 19.19 | 20.38 | 21.67 | 17.99 | 6.71 |
Machinery | 95.9 | 95.05 | 90.37 | 81.84 | 75.31 |
Construction In Progress | 257.91 | 148.34 | - | - | - |
Leasehold Improvements | 86.72 | 86.72 | 86.72 | 86.18 | 86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.